Evaluation of Efficacy and Tolerability of Hizentra® in Subjects Transitioning From Vivaglobin® (16% SCIG Product) to Hizentra® (20% SCIG Product)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01354587

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:17.650996+00:00

Published At

2012-07-17T00:00:00+00:00

Record Updated At

2012-07-17

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Primary Immunodeficiency Disorders"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2012-07-17"

protocolSection.identificationModule.nctId

"NCT01354587"

protocolSection.identificationModule.officialTitle

"Evaluation of Efficacy and Tolerability of Hizentra\u00ae in Subjects Transitioning From Vivaglobin\u00ae (16% SCIG Product) to Hizentra\u00ae (20% SCIG Product)"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Primary Immunodeficiency Disorders (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.